9191 Grant St, Thornton, CO, 80229 · (303) 451-7800
Beds
158
FY 2025
Star rating
3 of 5
Patient survey: 2 of 5
Net patient revenue
$271.0M
FY 2025
Net income
$30.1M
Patient care margin 10.9%
Discharges
8,454
Occupancy 66.0%
Clinicians
383
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $271.0M | $241.4M | 10.9% | $30.1M | 8,454 | $23.5M | 12.2% | 32.1% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 7.1% | US median 8.5% |
| Death rate for heart attack patients | 11.1% | US median 11.8% |
| Death rate for heart failure patients | 9.9% | US median 11% |
| Hospital-wide death rate within 30 days | 4.2% | US median 3.9% |
| Death rate for pneumonia patients | 16.3% | US median 15.2% |
| Death rate for stroke patients | 13.9% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $222.6M | $193.0M | 13.3% | $30.1M | 8,150 | $26.7M | 12.8% | 31.1% |
| 2023 | $171.3M | $168.4M | 1.7% | $3.5M | 7,421 | $12.8M | 13.0% | 35.3% |
| 2022 | $160.3M | $152.9M | 4.6% | $7.7M | 6,392 | $9.0M | 14.2% | 39.5% |
| 2021 | $183.1M | $159.0M | 13.2% | $24.4M | 7,047 | $10.4M | 14.9% | 37.9% |
| 2020 | $171.9M | $148.7M | 13.5% | $23.5M | 7,425 | $10.2M | 16.4% | 36.9% |
| Readmission rate for COPD | 19.2% | US median 19.8% |
| Readmission rate after a heart attack | 15% | US median 14.4% |
| Readmission rate for heart failure | 22% | US median 21.3% |
| Readmission rate for pneumonia | 17.1% | US median 17.2% |
| Serious complications (patient safety composite) | 0.91 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.25 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.00 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.91 | US median 0.72 |
| MRSA bloodstream infections (ratio to expected) | 0.67 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.00 | US median 0.40 |
| Doctors always communicated well | 68% | US median 79% |
| Nurses always communicated well | 69% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 50% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 56% | US median 72% |
| Room and bathroom always clean | 71% | US median 73% |
| Patients who would definitely recommend the hospital | 52% | US median 71% |
| Patients who left the emergency department before being seen | 0% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 126 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 13% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 68% | US median 65% |
| Healthcare workers given the flu vaccine | 79% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 85% | US median 74% |
| 38 |
| $109,796.16 |
| $9,638.29 |
| $9,973.97 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 35 | $114,652.31 | $10,205.91 | $9,867.73 |
| DRG 682 RENAL FAILURE WITH MCC | 29 | $128,447.03 | $11,255.93 | $11,457.18 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 22 | $85,810.73 | $7,390.64 | $7,681.44 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 22 | $148,682.00 | $12,201.09 | $13,076.55 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 21 | $173,376.14 | $12,164.05 | $12,400.10 |
| DRG 683 RENAL FAILURE WITH CC | 18 | $82,957.56 | $7,408.67 | $6,629.69 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 18 | $167,099.00 | $13,406.78 | $12,667.88 |
| DRG 552 MEDICAL BACK PROBLEMS WITHOUT MCC | 16 | $117,498.13 | $7,478.94 | $7,114.44 |
| DRG 322 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITHOUT MCC | 16 | $349,032.56 | $12,421.00 | $12,904.99 |
| DRG 321 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITH MCC OR 4+ ARTERIES/ | 13 | $440,121.38 | $20,351.23 | $22,190.93 |
| DRG 637 DIABETES WITH MCC | 12 | $178,825.42 | $10,782.58 | $11,464.10 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 11 | $96,289.18 | $6,797.09 | $5,829.71 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 56 | 54 | $2,076.07 | $2,090.36 |
| APC 5191 Level 1 Endovascular Procedures | 28 | 28 | $2,223.83 | $2,207.96 |
| APC 5193 Level 3 Endovascular Procedures | 27 | 27 | $8,499.69 | $8,873.86 |
| APC 5194 Level 4 Endovascular Procedures | 25 | 25 | $15,025.29 | $14,606.35 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 20 | 19 | $1,229.68 | $1,219.56 |
| APC 5183 Level 3 Vascular Procedures | 14 | 14 | $2,404.14 | $2,405.01 |
| APC 5361 Level 1 Laparoscopy and Related Services | 11 | 11 | $4,376.31 | $4,357.80 |
| APC 5415 Level 5 Gynecologic Procedures | - | - | - | $3,792.42 |
| APC 5416 Level 6 Gynecologic Procedures | - | - | - | $5,835.63 |
| APC 5432 Level 2 Nerve Procedures | - | - | - | $4,673.83 |
| APC 5465 Level 5 Neurostimulator and Related Procedures | - | - | - | $26,719.00 |
| APC 5471 Implantation of Drug Infusion Device | - | - | - | $14,828.75 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $8,000 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
HCA Healthone Mountain Ridge is a for-profit short-term acute care hospital in Thornton, CO with 158 beds, part of HCA Healthcare and a 3-star overall rating.
HCA Healthone Mountain Ridge in Thornton, CO has 158 beds (fiscal year 2025 cost report); 157 beds are certified for Medicare. It discharged 8,454 inpatients that year, with 66.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), HCA Healthone Mountain Ridge reported net patient revenue of $271.0M and operating expenses of $241.4M, a margin on patient care of 10.9%. After other income and expenses its net income was $30.1M (11.1% of revenue), so it made a profit that year.
HCA Healthone Mountain Ridge is part of HCA Healthcare (listed company, ticker HCA), a health system with 163 hospitals based in Nashville, TN. It is a for-profit hospital.
HCA Healthone Mountain Ridge has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
Yes, HCA Healthone Mountain Ridge provides emergency services.
383 Medicare clinicians list HCA Healthone Mountain Ridge as a hospital they work at, most often in Internal Medicine, Family Practice, Diagnostic Radiology.
In 2024, HCA Healthone Mountain Ridge had 445 Medicare inpatient stays in 15 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 134 stays; Medicare paid $14,056.16 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $8,000 in payments to HCA Healthone Mountain Ridge as a teaching hospital ($8,000 general and - for research) from 1 companies.